2025年全球數位治療市場報告

近年來，數位治療市場呈指數級成長，從2024年的87.3億美元成長到2025年的109.3億美元，複合年成長率達25.2%。預測期內的成長主要受人口老化和慢性病需求、數位醫療的普及、醫療成本和效率、遠端患者監護以及疫情等因素所驅動。

預計未來幾年，數位治療市場規模將呈指數級成長，到2029年將達到295.6億美元，複合年成長率為28.2%。預測期內的成長可歸因於個人化醫療、醫療資料互通性、基於價值的照護模式的日益普及，對心理健康和福祉、醫療保健可近性和公平性的日益關注，網路安全和資料保護的不斷擴展，以及對人口健康管理需求的不斷成長。預測期內的主要趨勢包括物聯網設備和感測器的擴展、醫療保健領域的人工智慧、穿戴式健康技術、技術進步和產品創新。

數位療法 (DTx) 是指透過複雜的軟體應用程式向患者提供實證治療方法的產品。這些應用程式旨在預防、管理和治療各種醫療狀況和疾病。

數位治療產品的主要類別是設備和軟體。數位治療設備提供介入措施，用於預防、管理或治療疾病或醫學病症。數位治療設備包含監測藥物使用情況和位置的感測器。數位治療的銷售管道包括企業對企業 (B2B) 和企業對消費者 (B2C)。數位治療可應用於預防、治療和護理。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 全新報告系列的一部分，該系列提供數位治療市場統計數據，例如全球數位治療行業市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的數位治療細分市場、市場趨勢和商業機會，以及在數位治療行業取得成功所需的數據。本數位治療市場研究報告全面展望了所有必要資訊，並深入分析了該行業的現狀和未來發展趨勢。

預測的五年成長率為28.2%，較我們先前對該市場的預測略有下降0.3%。下降的主要原因是美國與其他國家之間的關稅影響，這可能會直接影響到美國，導致來自英國和愛爾蘭等主要地區的認知行為療法軟體平台和食品藥物管理局(FDA) 批准的醫療設備零件的供應鏈中斷。

智慧型手機和平板電腦的快速普及，以及醫療保健應用程式的預期廣泛應用，預計將推動數位治療市場的持續成長。智慧型手機和平板電腦上醫療保健應用程式的廣泛應用帶來了許多益處，包括減少用藥錯誤、增強預防性護理以及提高人員分配的準確性。根據英國非營利組織GSMA（全球行動通訊系統協會）發布的《2023年行動網路連線狀況報告》，2022年，全球超過一半的人口（54%）將擁有智慧型手機。智慧型手機的廣泛普及是數位治療市場的關鍵驅動力，創造了有利於創新治療性介入發展的環境。

慢性病盛行率的上升是推動數位治療市場擴張的關鍵因素。慢性病的特徵是需要長期治療，且嚴重影響個人的日常生活。作為軟體為基礎的介入手段，數位治療提供實證治療方案，增強慢性病管理，為患者提供新的治療選擇。根據美國疾病管制與預防中心2022年7月發布的數據，美國每10個成年人中就有6人患有慢性病，每10人中就有4人患有兩種或兩種以上的慢性病，​​例如心臟病、糖尿病和慢性肺病。慢性病的盛行率顯著推動了數位治療市場的成長軌跡。

技術創新是數位治療市場的新興趨勢，產業領導者專注於開發先進的解決方案以增強其市場佔有率。德國領先的製藥公司勃林格殷格翰和美國醫療保健數位治療公司 Click Pharmaceuticals 合作開發和商業化一種針對思覺失調症患者的數位藥物。該合作夥伴關係價值超過 5 億美元，凸顯了兩家公司對利用技術進步的承諾。提案的治療藥物 CT-155 將是基於 Click 技術平台開發的行動應用程式，展示創新數位解決方案在治療領域的整合。這項策略性夥伴關係關係反映了業界致力於推進和整合技術，以改善數位治療市場的治療選擇和患者預後。

數位治療市場的主要企業正在積極開發創新的訂購、履約平台，以服務慢性病患者。例如，DTx Connect 平台旨在透過軟體直接向患者提供治療性介入，以應對各種疾病和障礙，包括心理健康問題和糖尿病。 2022 年 7 月，美國製藥解決方案公司 AmerisourceBergen 宣布推出 DTx Connect，這是一個完全整合的訂購、配藥和履約平台。 DTx Connect 平台的主要功能包括與電子健康記錄(EMR) 無縫整合，使醫生能夠透過電子處方工作流程存取和開立處方箋和非處方箋數位療法。該平台還有助於監測患者的依從性，從而簡化醫療保健提供者的流程。

2023 年 7 月，Big Health 收購了 Limbix，收購金額不詳，旨在擴大其現有產品系列。 Big Health 的產品組合包括失眠治療藥物 Threepio 和焦慮治療藥物日間行車燈。收購 Limbix 將增加 Sparklex 和另一種正在開發的用於治療焦慮的青少年藥物。 Limix 是一家總部位於美國的數位治療供應商，將為 Big Health 的產品組合增添寶貴資產，增強其提供全面數位治療解決方案的能力。此次收購反映了數位治療市場的動態格局，標誌著 Big Health 擴大產品系列、滿足不同健康狀況患者的多樣化需求的策略性舉措。

數位治療市場的主要參與者包括 Omada Health Inc.、WellDoc Inc.、2Morrow Inc.、Propeller Health、Pear Therapeutics、Canary Health Inc.、Noom Health Inc.、Akili Interactive Labs、Better Therapeutics、Happify Health、Kaia Health、Medtronic plc、TelHealthc、Better Therapeutics、Happify Health. Health、SilverCloud Health、Biofourmis Inc.、Prosoma、Virta Health Corp.、One Drop Inc.、Lark Health、Riva、Xealth 和 CogniFit Ltd.。

2024年，北美是數位治療市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。數位治療市場分析報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

數位治療市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

數位治療市場涵蓋用於治療疾病、管理病情或改善健康功能的產品銷售。此市場的價值是指“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球數位治療：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球數位治療市場：成長率分析
• 全球數位治療市場表現：規模與成長，2019-2024
• 全球數位治療市場預測：2024-2029 年及 2034 年規模與成長
• 全球數位治療：總目標市場（TAM）

第6章 市場細分

• 全球數位治療市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 軟體
• 裝置
• 全球數位治療市場：按銷售管道、業績和預測，2019-2024 年、2024-2029 年、2034 年
• 企業對企業（B2B）
• 企業對消費者（B2C）
• 全球數位治療市場：按應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 預防性應用
• 治療或護理相關應用
• 全球數位治療市場：依軟體（類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 行動應用程式
• 網路為基礎的平台
• 數位治療軟體
• 全球數位治療市場：按設備（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 穿戴式裝置
• 生物感測器
• 數位治療設備

第7章 區域和國家分析

• 全球數位治療市場：區域表現與預測（2019-2024 年、2024-2029 年及 2034 年）
• 全球數位治療市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 數位治療市場：競爭格局
• 數位治療市場：公司簡介
  • Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • WellDoc Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 2Morrow Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Propeller Health Overview, Products and Services, Strategy and Financial Analysis
  • Pear Therapeutics Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Canary Health Inc.
• Noom Health Inc.
• Akili Interactive Labs
• Better Therapeutics
• Happify Health
• Kaia Health
• Medtronic plc
• Teladoc Health Inc.
• Fitbit Health Solutions
• EMulate Therapeutics
• BigHealth
• DarioHealth
• IQVIA
• JOGO Health
• SilverCloud Health

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年數位治療市場：提供新機會的國家
• 2029年數位治療市場：細分領域帶來新機會
• 2029年數位治療市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Digital therapeutics (DTx) represent products that deliver evidence-based therapeutic treatments to patients through sophisticated software applications. These applications aim to prevent, manage, or treat various medical ailments or diseases.

The primary categories of digital therapeutics products encompass devices and software. Digital therapeutics devices offer interventions for the prevention, management, or treatment of diseases or medical disorders. This may involve sensors utilized to monitor medication usage and location data. The sales channels for digital therapeutics include both business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics find applications in both preventive and treatment or care-related contexts.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics market size has grown exponentially in recent years. It will grow from $8.73 billion in 2024 to $10.93 billion in 2025 at a compound annual growth rate (CAGR) of 25.2%. The growth in the historic period can be attributed to aging population and chronic diseases, digital health adoption, healthcare costs and efficiency, remote patient monitoring, and pandemic-induced demand.

The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $29.56 billion in 2029 at a compound annual growth rate (CAGR) of 28.2%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine, health data interoperability, value-based care models, increasing mental health and well-being focus, healthcare access and equity, growing cybersecurity and data protection, growing demand for population health management. Major trends in the forecast period include expansion of iot devices and sensors, artificial intelligence in healthcare, wearable health technology, technological advancements, and product innovations.

The forecast of 28.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for cognitive behavioral therapy software platforms and Food and Drug Administration (FDA)-cleared medical device components, sourced from key regions such as the UK and Ireland, which could lead to delayed prescription digital treatment availability and increased development costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in the use of smartphones and tablets, complemented by the widespread adoption of healthcare apps, is expected to drive the growth of the digital therapeutics market in the foreseeable future. The prevalence of smartphones and tablet-based healthcare apps brings about numerous advantages, including a reduction in medication errors, facilitating preventive care, and improving staffing accuracy. According to the State of Mobile Internet Connectivity Report 2023 by Groupe Speciale Mobile Association (GSMA), a UK-based non-profit organization, the year 2022 saw more than half of the world's population (54%) owning smartphones. This widespread use of smartphones is a significant driver for the digital therapeutics market, fostering a conducive environment for the growth of innovative therapeutic interventions.

The growing incidence of chronic diseases is poised to be a key driver propelling the expansion of the digital therapeutics market. Chronic diseases, characterized by long-lasting conditions requiring extended medical attention, significantly impact individuals' daily lives. Digital therapeutics, as software-based interventions, offer evidence-based therapeutic solutions to enhance the management of chronic diseases, providing patients with additional treatment options. Notably, data from the Centers for Disease Control and Prevention in July 2022 highlighted that six out of ten adults in the US are affected by chronic diseases, with four out of ten adults experiencing more than two chronic conditions such as heart disease, diabetes, and chronic lung diseases. This prevalence of chronic diseases contributes substantially to the growth trajectory of the digital therapeutics market.

An emerging trend in the digital therapeutics market is technological innovation, with major industry players focusing on developing advanced solutions to strengthen their market presence. Boehringer Ingelheim, a leading pharmaceutical company based in Germany, and Click Pharmaceuticals, a US-based prescription digital therapeutics business, have entered into a collaboration to develop and commercialize a digital medication for schizophrenia patients. This collaboration, valued at over $500 million, underscores the commitment to leveraging technological advancements. The proposed treatment, CT-155, will be a mobile app developed on Click's technology platform, showcasing the integration of innovative digital solutions in the field of therapeutics. This strategic partnership reflects the industry's dedication to advancing and integrating technology to enhance treatment options and patient outcomes in the digital therapeutics market.

Major players in the digital therapeutics market are actively developing innovative ordering, dispensing, and fulfillment platforms to cater to patients dealing with chronic diseases. An exemplar in this regard is DTx Connect, a platform designed to deliver therapeutic interventions directly to patients through software, addressing a spectrum of diseases and disorders including mental health issues and diabetes. In July 2022, AmerisourceBergen, a pharmaceutical solutions organization based in the US, introduced DTx Connect, a fully integrated platform for ordering, dispensing, and fulfillment. Key features of the DTx Connect platform include seamless integration with electronic medical records (EMR), enabling physicians to access and prescribe both prescription and non-prescription digital therapeutics through their e-prescribing workflow. The platform also facilitates the monitoring of patient fulfillment, streamlining the process for healthcare providers.

In July 2023, Big Health acquired Limbix for an undisclosed amount, aiming to expand its existing product portfolio. Big Health's product range includes Sleepio for insomnia and Daylight for anxiety, and with the acquisition of Limbix, it incorporates SparkRx and another teenage medication in development for anxiety. Limbix, a US-based provider of digital therapeutics, adds valuable assets to Big Health's offerings, enhancing its capabilities in providing a comprehensive suite of digital therapeutic solutions. This acquisition reflects the dynamic landscape of the digital therapeutics market, characterized by strategic moves to broaden product portfolios and meet the diverse needs of patients dealing with various health conditions.

Major companies operating in the digital therapeutics market include Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Riva, Xealth, CogniFit Ltd.

North America was the largest region in the digital therapeutics market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutic market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Software; Devices
• 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
• 3) By Application: Preventive Applications; Treatment Or Care-Related Applications
• Subsegments:
• 1) By Software: Mobile Applications; Web-Based Platforms; Digital Therapeutics Software
• 2) By Devices: Wearable Devices; Biosensors; Digital Therapeutic Devices
• Companies Mentioned: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Propeller Health; Pear Therapeutics; Canary Health Inc.; Noom Health Inc.; Akili Interactive Labs; Better Therapeutics; Happify Health; Kaia Health; Medtronic plc; Teladoc Health Inc.; Fitbit Health Solutions; EMulate Therapeutics; BigHealth; DarioHealth; IQVIA; JOGO Health; SilverCloud Health; Biofourmis Inc.; Prosoma; Virta Health Corp.; One Drop Inc.; Lark Health; Riva; Xealth; CogniFit Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics Market Characteristics

3. Digital Therapeutics Market Trends And Strategies

4. Digital Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Digital Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Digital Therapeutics Market Growth Rate Analysis
• 5.4. Global Digital Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Digital Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Digital Therapeutics Total Addressable Market (TAM)

6. Digital Therapeutics Market Segmentation

• 6.1. Global Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Devices
• 6.2. Global Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Business-To-Business (B2B)
• Business-To-Consumers (B2C)
• 6.3. Global Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preventive Applications
• Treatment Or Care-Related Applications
• 6.4. Global Digital Therapeutics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Applications
• Web-Based Platforms
• Digital Therapeutics Software
• 6.5. Global Digital Therapeutics Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Devices
• Biosensors
• Digital Therapeutic Devices

7. Digital Therapeutics Market Regional And Country Analysis

• 7.1. Global Digital Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Digital Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics Market

• 8.1. Asia-Pacific Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics Market

• 9.1. China Digital Therapeutics Market Overview
• 9.2. China Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics Market

• 10.1. India Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics Market

• 11.1. Japan Digital Therapeutics Market Overview
• 11.2. Japan Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics Market

• 12.1. Australia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics Market

• 13.1. Indonesia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics Market

• 14.1. South Korea Digital Therapeutics Market Overview
• 14.2. South Korea Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics Market

• 15.1. Western Europe Digital Therapeutics Market Overview
• 15.2. Western Europe Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics Market

• 16.1. UK Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics Market

• 17.1. Germany Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics Market

• 18.1. France Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics Market

• 19.1. Italy Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics Market

• 20.1. Spain Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics Market

• 21.1. Eastern Europe Digital Therapeutics Market Overview
• 21.2. Eastern Europe Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics Market

• 22.1. Russia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics Market

• 23.1. North America Digital Therapeutics Market Overview
• 23.2. North America Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics Market

• 24.1. USA Digital Therapeutics Market Overview
• 24.2. USA Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics Market

• 25.1. Canada Digital Therapeutics Market Overview
• 25.2. Canada Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics Market

• 26.1. South America Digital Therapeutics Market Overview
• 26.2. South America Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics Market

• 27.1. Brazil Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics Market

• 28.1. Middle East Digital Therapeutics Market Overview
• 28.2. Middle East Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics Market

• 29.1. Africa Digital Therapeutics Market Overview
• 29.2. Africa Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Digital Therapeutics Market Competitive Landscape
• 30.2. Digital Therapeutics Market Company Profiles
  • 30.2.1. Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. WellDoc Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. 2Morrow Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Propeller Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pear Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics Market Other Major And Innovative Companies

• 31.1. Canary Health Inc.
• 31.2. Noom Health Inc.
• 31.3. Akili Interactive Labs
• 31.4. Better Therapeutics
• 31.5. Happify Health
• 31.6. Kaia Health
• 31.7. Medtronic plc
• 31.8. Teladoc Health Inc.
• 31.9. Fitbit Health Solutions
• 31.10. EMulate Therapeutics
• 31.11. BigHealth
• 31.12. DarioHealth
• 31.13. IQVIA
• 31.14. JOGO Health
• 31.15. SilverCloud Health

32. Global Digital Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Market

34. Recent Developments In The Digital Therapeutics Market

35. Digital Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Digital Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Digital Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Digital Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer